Literature DB >> 17687839

Epidemiology and cost of haemodialysis in Jordan.

A Batieha1, S Abdallah, M Maghaireh, Z Awad, N Al-Akash, A Batieneh, K A Ajlouni.   

Abstract

To assess the epidemiology and burden of haemodialysis in Jordan, all patients on haemodialysis (1711 patients) were surveyed during September/October 2003. Mean age was 48.9 years, 56% were male, 86.8% were unemployed and 92% were poor. Mean distance to the haemodialysis service was 13.6 km. Annual hepatitis B and C seroconversion for patients negative before dialysis was 0.34% and 2.6% respectively. Prevalence of haemodialysis was 312 per million population; the incidence in 2002 was 111 per million population. Fatality rate at 1 year was 20%. Diabetes mellitus was the leading cause of haemodialysis, 29.2% of cases. Total estimated cost of haemodialysis in 2003 was US$ 29.7 million.

Entities:  

Mesh:

Year:  2007        PMID: 17687839

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  10 in total

1.  Incidence and prevalence of hepatitis B and hepatitis C viruses in hemodialysis patients in Lebanon.

Authors:  Antoine Abou Rached; Lara El Khoury; Talal El Imad; Abdallah S Geara; Josette Jreijiry; Walid Ammar
Journal:  World J Nephrol       Date:  2016-01-06

2.  Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya.

Authors:  Wiam A Alashek; Christopher W McIntyre; Maarten W Taal
Journal:  BMC Nephrol       Date:  2012-06-08       Impact factor: 2.388

Review 3.  The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis.

Authors:  Hiam Chemaitelly; Karima Chaabna; Laith J Abu-Raddad
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

4.  End-Stage Kidney Failure in Oman: An Analysis of Registry Data with an Emphasis on Congenital and Inherited Renal Diseases.

Authors:  Intisar Al Alawi; Issa Al Salmi; Adhra Al Mawali; Yacoub Al Maimani; John A Sayer
Journal:  Int J Nephrol       Date:  2017-06-08

Review 5.  Costs associated with management of non-communicable diseases in the Arab Region: a scoping review.

Authors:  Shadi Saleh; Amena El Harakeh; Maysa Baroud; Najah Zeineddine; Angie Farah; Abla Mehio Sibai
Journal:  J Glob Health       Date:  2018-12       Impact factor: 4.413

6.  Cryptosporidiosis among Hemodialysis Patients in Jordan: First Preliminary Screening Surveillance.

Authors:  AbdelRahman M Zueter; Nawal S Hijjawi; Khaled N Hamadeneh; Maysa M Al-Sheyab; Amal M Hatamleh
Journal:  Trop Med Infect Dis       Date:  2019-10-18

7.  Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors.

Authors:  Wiam A Alashek; Christopher W McIntyre; Maarten W Taal
Journal:  BMC Infect Dis       Date:  2012-10-20       Impact factor: 3.090

8.  A cost analysis of kidney replacement therapy options in Palestine.

Authors:  Mustafa Younis; Samer Jabr; Abdallah Al-Khatib; Dana Forgione; Michael Hartmann; Adnan Kisa
Journal:  Inquiry       Date:  2015-03-11       Impact factor: 1.730

9.  Hepatitis B care pathway in Jordan: current situation, gaps and recommended actions.

Authors:  Majed Nusair; Yaser Rayyan; Waseem Hammoudeh; Mohammed Amer Al-Khatib; Eid Mansour; Snehanshu Snehanshu; Nathalie Bassil; Sam Kozma; Imad Al Ghazzawi
Journal:  J Virus Erad       Date:  2020-02-20

Review 10.  Epidemiology of hepatitis C virus among hemodialysis patients in the Middle East and North Africa: systematic syntheses, meta-analyses, and meta-regressions.

Authors:  M Harfouche; H Chemaitelly; S Mahmud; K Chaabna; S P Kouyoumjian; Z Al Kanaani; L J Abu-Raddad
Journal:  Epidemiol Infect       Date:  2017-10-09       Impact factor: 4.434

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.